Gilead Sciences (Brazil) Price Prediction
| GILD34 Stock | BRL 287.56 4.47 1.58% |
Oversold Vs Overbought
57
Oversold | Overbought |
Using Gilead Sciences hype-based prediction, you can estimate the value of Gilead Sciences from the perspective of Gilead Sciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Gilead Sciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Gilead because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Gilead Sciences after-hype prediction price | BRL 287.56 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Gilead |
Gilead Sciences After-Hype Price Prediction Density Analysis
As far as predicting the price of Gilead Sciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Gilead Sciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Gilead Sciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Gilead Sciences Estimiated After-Hype Price Volatility
In the context of predicting Gilead Sciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Gilead Sciences' historical news coverage. Gilead Sciences' after-hype downside and upside margins for the prediction period are 285.84 and 289.28, respectively. We have considered Gilead Sciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Gilead Sciences is very steady at this time. Analysis and calculation of next after-hype price of Gilead Sciences is based on 3 months time horizon.
Gilead Sciences Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Gilead Sciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Gilead Sciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Gilead Sciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.39 | 1.73 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
287.56 | 287.56 | 0.00 |
|
Gilead Sciences Hype Timeline
Gilead Sciences is currently traded for 287.56on Sao Paulo Exchange of Brazil. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Gilead is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is currently at 0.39%. %. The volatility of related hype on Gilead Sciences is about 0.0%, with the expected price after the next announcement by competition of 287.56. The company has Price/Earnings To Growth (PEG) ratio of 0.71. Gilead Sciences recorded earning per share (EPS) of 9.63. The entity last dividend was issued on the 14th of March 2023. Assuming the 90 days trading horizon the next expected press release will be in a few days. Check out Gilead Sciences Basic Forecasting Models to cross-verify your projections. For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.Gilead Sciences Related Hype Analysis
Having access to credible news sources related to Gilead Sciences' direct competition is more important than ever and may enhance your ability to predict Gilead Sciences' future price movements. Getting to know how Gilead Sciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Gilead Sciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MRCK34 | Merck Co | 0.00 | 0 per month | 2.12 | (0.02) | 2.87 | (2.85) | 17.23 | |
| ABBV34 | AbbVie Inc | 0.00 | 0 per month | 2.47 | 0.04 | 3.67 | (4.40) | 15.14 | |
| BMYB34 | Bristol Myers Squibb | 0.00 | 0 per month | 1.28 | 0.17 | 3.90 | (3.08) | 16.31 | |
| GILD34 | Gilead Sciences | 0.00 | 0 per month | 1.55 | 0.19 | 2.10 | (2.91) | 12.72 | |
| BIIB34 | Biogen Inc | 0.00 | 0 per month | 0.00 | (0.20) | 1.69 | (2.51) | 11.91 |
Gilead Sciences Additional Predictive Modules
Most predictive techniques to examine Gilead price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Gilead using various technical indicators. When you analyze Gilead charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Gilead Sciences Predictive Indicators
The successful prediction of Gilead Sciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Gilead Sciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Gilead Sciences based on analysis of Gilead Sciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Gilead Sciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Gilead Sciences's related companies.
Story Coverage note for Gilead Sciences
The number of cover stories for Gilead Sciences depends on current market conditions and Gilead Sciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Gilead Sciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Gilead Sciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Gilead Sciences Short Properties
Gilead Sciences' future price predictability will typically decrease when Gilead Sciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Gilead Sciences often depends not only on the future outlook of the potential Gilead Sciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Gilead Sciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.2 B |
Complementary Tools for Gilead Stock analysis
When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |